Drug
Interferon alfacon-1 clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 2
Sichuan Huiyang Life Science and Technology Corporation (3) · Astellas Pharma Inc (1) · Beth Israel Medical Center (1) · Kadmon Corporation, LLC (1) · University Health Network, Toronto (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses interferon alfacon-1 is read from its arms, and is right about nine times in ten.
Testing it · 7
- rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19CompletedPhase 2Sichuan Huiyang Life Science and Technology CorporationNCT05485584Written as rSIFN-co Nasal Spray
- Study of rSIFN-co for Patients With Advanced Solid TumorsTerminatedPhase 1Sichuan Huiyang Life Science and Technology CorporationNCT02464007Written as rSIFN-co
- A Study of rSIFN-co in Subjects With Advanced Solid TumorsCompletedPhase 1Sichuan Huiyang Life Science and Technology CorporationNCT02387307Written as rSIFN-co
- Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis CCompletedPhase 3Astellas Pharma IncNCT00239252Written as Interferon alfacon-1
- Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and RibavirinTerminatedPhase 4Kadmon Corporation, LLCNCT00456248Written as Infergen and ribavirin
- Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for InfluenzaStatus unknownPhase 1/2University Health Network, TorontoNCT01227798Written as Interferon alfacon-1
- Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior TherapyCompletedPhase 4Beth Israel Medical CenterNCT00266318Written as Interferon Alfacon-1 and Ribavirin
Given in every arm · 1 — interferon alfacon-1 is usual care beside what is tested
As the comparator · 1 — what is tested is compared with interferon alfacon-1
Codes
What other systems call interferon alfacon-1 · ClinicalTrials.gg INT003304
- MeSH (NLM) C050739interferon alfacon-1Confirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 56588OP40DINTERFERON ALFACON-1Confirmed FDA, NLM, Wikidata
- RxNorm 59744Confirmed FDA, Wikidata
- Wikidata Q15353101interferon alfacon-1Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C1766Interferon Alfacon-1One source FDA
- DrugBank DB00069One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C050739 | interferon alfacon-1 | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 56588OP40D | INTERFERON ALFACON-1 | Confirmed FDA, NLM, Wikidata |
| RxNorm | 59744 | — | Confirmed FDA, Wikidata |
| Wikidata | Q15353101 | interferon alfacon-1 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1766 | Interferon Alfacon-1 | One source FDA |
| DrugBank | DB00069 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.